Descriptive Study of the PSYchological Impact of CONFinement Measures in the General Population

• Conditions: Depression; COVID 19
• Interventions: Other: Slef questionnaires fulfilment

• Registration Number: NCT04374643
• Lead Sponsor: University Hospital, Montpellier

Brief Summary

Quarantine is an unpleasant experience : separation from loved ones, loss of freedom, uncertainty about infection status, boredom. It may lead to negative mental health consequences and thus the emergence of anxiety and depressive symptoms.

From March 17th, 2020 to May 11th 2002, the French government has implemented national containment measures due to the Covid-19 epidemic.

Although there are data on the psychological impact and experience of quarantine measures in people who have been infected or suspected of being carriers of certain pathogens (e.g. Ebola), there are no data on such impact in the French population and quarantines lasting longer than 21 days. Investigators therefore propose to conduct a human and social sciences study in order to better understand the current situation

Detailed Description

The main objective is to describe the psychological state during confinement (and the impact of the confinement) in a sample of the French general population.

Secondary objectives :

* to assess the evolution of psychological health between the period of confinement and post-confinement.

* to identify clinical factors modulating psychological state during confinement

It is expected to highlight :

* a link between the intensity of anxiety symptoms and the number/quality of social contacts

* a reduction of anxiety and depression symptoms in the post-confinement period.

* higher consumption of drugs during the confinement period

Self-questionnaires (Google form format) are sent by mailing lists or social networks to participants in order to complete the assessment of psychological state. A unique identifier is sent in a separate email. These assessments are performed at least once during the confinement period. It is planned to repeat them when the confinement is lifted: 15 days, 3 and 6 months after the lifting of the confinement because of the risk of developing anxiodepressive symptoms, in particular post-traumatic stressors.

Study Timeline

• Study Start: 2020-04-01
• Study First Submitted: 2020-04-30
• Study First Submitted QC: 2020-04-30
• Study First Posted: 2020-05-05
• Status Verified: 2020-12
• Last Update Submitted: 2020-12-28
• Last Update Posted: 2020-12-29
• Primary Completion: 2021-12-01
• Study Completion: 2021-12-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Confined patients	Slef questionnaires fulfilment	General population

Primary Outcome Measures

Name	Time	Method
Depressive Symptomatology	during confinement	depressive symptomatology with Patient Health Questionnaire : PHQ-9 scale (PHQ 9 higher score, more depressive -\> min : 0 max : 27)

Secondary Outcome Measures

Name	Time	Method
Depressive Symptomatology	post-confinement : 15 days, 3 months, 6 months	depressive symptomatology with Patient Health Questionnaire : PHQ-9 scale (PHQ 9 higher score, more depressive -\> min : 0 max : 27)

Trial Locations

Locations (1)

University hospital; 🇫🇷 Montpellier, France